Galectin Therapeutics Inc. (GALT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Galectin Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$3.54
+4.73% today
Market cap
$342M
Overall quality
43/100
Kronos AI 30-day
−7.2%
3 of 8 simulated paths end higher
Galectin Therapeutics Inc. (GALT) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $342M. It trades at $3.54, up 4.73% today. Its overall quality score is 43 out of 100, ranked against the whole US market. 1 analysts' average target of $11.00 implies +210.7% from today's price. Kronos AI's 30-day forecast is −7.2% (3 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $11.00 |
| Low – high | $11.00 – $11.00 |
| Analysts | 1 |
| Upside to average | +210.7% |
Kronos AI 30-day forecast
| Expected close | $3.14 (−7.2%) |
| Likely range | −14.5% … +11.3% |
| As of | 2026-10-27 |
3 of 8 simulated paths end higher.
Quality scores
| Profitability | 50 |
| Solvency | 33 |
| Growth | 46 |
| Overall | 43 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.